Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
People with spinal cord injuries often lose movement even though their brains still send the right signals. Researchers ...
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...
In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...
TAMPA, Fla., Jan. 13, 2026 /PRNewswire/ -- PainTEQ, a medical device company dedicated to advancing minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced the appointment ...
I’m a neurosurgeon specializing in pain and functional neurosurgical disorders. I received my medical training at Loyola University and completed my neurosurgery residency and functional neurosurgery ...
School is back in session for the pupils and teachers of Abbott Elementary after a much-needed winter break. After learning some not-so good news about the state of the school, the Abbott crew is ...
The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...